Transport of the phosphonodipeptide alafosfalin by the H +/peptide cotransporters PEPT1 and PEPT2 in intestinal and renal epithelial cells

European Journal of Biochemistry

Volumn 271, Issue 10, 2004, Pages 2012-2017

  Neumann, Jana ^a   Bruch, Mandy ^a   Gebauer, Sabine ^a   Brandsch, Matthias ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Alafosfalin; Alaphosphin; Caco 2 cells; SKPT cells; Ussing technique

Indexed keywords

ALAFOSFALIN; CARBON 14; GLYCYLSARCOSINE; MANNITOL; PEPTIDE TRANSPORTER 1; PEPTIDE TRANSPORTER 2; PROTEIN DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CELL CULTURE; CELL STRAIN CACO 2; DEVICE; DRUG PROTEIN BINDING; DRUG TRANSPORT; FILTER; HUMAN; HUMAN CELL; INTESTINE EPITHELIUM CELL; KIDNEY EPITHELIUM; KINETICS; MONOLAYER CULTURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN TRANSPORT; SHORT CIRCUIT CURRENT;

ALANINE; ANIMALS; BIOLOGICAL TRANSPORT; CACO-2 CELLS; CARBON RADIOISOTOPES; CARRIER PROTEINS; CELL LINE; DIPEPTIDES; ELECTROPHYSIOLOGY; EPITHELIAL CELLS; HUMANS; INTESTINES; INTRACELLULAR SPACE; KIDNEY; RATS; SYMPORTERS;

ANIMALIA; MAMMALIA;

EID: 2442688922     PISSN: 00142956     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1432-1033.2004.04114.x     Document Type: Article

References (31)

1. Allen, J.G., Atherton, F.R., Hall, M.J., Hassall, C.H., Holmes, S.W., Lambert, R.W., Nisbet, L.J. & Ringrose, P.S. (1978) Phosphonopeptides, a new class of synthetic antibacterial agents. Nature 272, 56-58.
2. Arisawa, M., Ohshima, J., Ohsawa, E. & Maruyama, H.B. (1982) In vitro potentiation of cephalosporins by alafosfalin against urinary tract bacteria. Antimicrob. Agents Chemother. 21, 706-710.
3. Westmacott, D., Hall, M., Hassall, C., Lees, L., Rowe, B. & Ward, L. (1982) Activity of alafosfalin against bacterial pathogens of the gastrointestinal tract in vitro and in vivo. Current chemotherapy and immunotherapy: Proceedings 12th Int. Congr. Chemother. 1, 340-342.
4. Maruyama, H.B., Arisawa, M. & Sawada, T. (1979) Alafosfalin, a new inhibitor of cell wall biosynthesis: in vitro activity against urinary isolates in Japan and potentiation with β-lactams. Antimicrob. Agents Chemother. 16, 444-451.
5. Atherton, F.R., Hall, J.H., Hassall, C.H., Holmes, S.W., Lambert, R.W., Lloyd, W.J. & Ringrose, P.S. (1980) Phosphonopeptide antibacterial agents related to alafosfalin: design, synthesis, and structure-activity relationships. Antimicrob. Agents Chemother. 18, 897-905.
6. Welling, P.G., Kendall, M.J. & Dean, S. (1980) Effect of food on the bioavailability of alafosfalin, a new antibacterial agent. J. Antimicrob. Chemother. 6, 373-379.
7. Kafarski, P. & Lejczak, B. (2001) Aminophosphonic acids of potential medical importance. Curr. Med. Chem. Anti-Cane. Agents 1, 301-312.
8. 99mTc]Alafosfalin: an antibiotic peptide infection imaging agent. Nucl. Med. Biol. 30, 169-175.
9. Druggan, P. (2002) Improvements in or relating to selective agents for biological cultures. PCT International Application Patent no. WO022785.
10. Perry, J.D., Riley, G., Gould, F.K., Perez, J.M., Boissier, E., Ouedraogo, R.T. & Freydière, A.M. (2002) Alafosfalin as a selective agent for isolation of Salmonella from clinical samples. J. Clin. Microbiol. 40, 3913-3916.
11. Nisbet, T.M. & Payne, J.W. (1982) The characteristics of peptide uptake in Streptococcus faecalis: studies on the transport of natural peptides and antibacterial phosphonopeptides. J. Gen. Microbiol. 128, 1357-1364.
12. Atherton, F.R., Hall, M.J., Hassall, C.H., Lambert, R.W., Lloyd, W.J., Lord, A.V., Ringrose, P.S. & Westmacott, D. (1983) Phosphonopeptides as substrates for peptide transport systems and peptidases of Escherichia coli. Antimicrob. Agents Chemother. 24, 522-528.
13. Grappel, S.F., Giovenella, A.J. & Nisbet, L.J. (1985) Activity of a peptidyl prodrug, alafosfalin, against anaerobic bacteria. Antimicrob. Agents Chemother. 27, 961-963.
14. Smith, M.W. & Payne, J.W. (1990) Simultaneous exploitation of different peptide permeases by combinations of synthetic peptide smugglins can lead to enhanced antibacterial activity. FEMS Microbiol. Lett. 58, 311-316.
15. Rubio-Aliaga, I. & Daniel, H. (2002) Mammalian peptide transporters as targets for drug delivery. Trends Pharmacol. Sci. 23, 434-440.
16. Daniel, H. & Rubio-Aliaga, I. (2003) An update on renal peptide transporters. Am. J. Physiol. Renal Physiol. 284, F885-F892.
17. +/peptide symporter PEPT1: structure-affinity relationships. Eur. J. Pharm. Sci. 21, 53-60.
18. Daniel, H. & Kottra, G. (2004) The proton oligopeptide cotransporter family SLC15 in physiology and pharmacology. Pflugers Arch. 447, 610-618.
19. Brodin, B., Nielsen, C.U., Steffansen, B. & Frokjaer, S. (2002) Transport of peptidomimetic drugs by the intestinal di/tri-peptide transporter, PepT1. Pharmacol. Toxicol. 90, 285-296.
20. +/peptide symporter (PEPT1), the uptake into Caco-2 cell monolayers and the transepithelial flux. Pharm. Res. 16, 55-61.
21. Nielsen, C.U., Brodin, B., Jorgensen, F.S., Frokjaer, S. & Steffansen, B. (2002) Human peptide transporters: therapeutic applications. Expert Opin. Ther. Patents 12, 1329-1349.
22. Ganapathy, M.E., Brandsch, M., Prasad, P.D., Ganapathy, V. & Leibach, F.H. (1995) Differential recognition of β-lactam antibiotics by intestinal and renal peptide transporters, PEPT 1 and PEPT 2. J. Biol. Chem. 270, 25672-25677.
23. Neumann, J. & Brandsch, M. (2003) δ-Aminolevulinic acid transport in cancer cells of the human extrahepatic biliary duct. J. Pharmacol. Exp. Ther. 305, 219-224.
24. +/ peptide cotransporter. FASEB J. 9, 1489-1496.
25. Shu, C., Shen, H., Hopfer, U. & Smith, D.E. (2001) Mechanism of intestinal absorption and renal reabsorption of an orally active ace inhibitor: uptake and transport of fosinopril in cell cultures. Drug Metab. Dispos. 29, 1307-1315.
26. +/peptide cotransport system, PEPT1. Eur. J. Biochem. 255, 698-702.
27. +/peptide symporter. Eur. J. Biochem. 266, 502-508.
28. Knütter, I., Hartrodt, B., Theis, S., Foltz, M., Rastetter, M., Daniel, H., Neubert, K. & Brandsch, M. (2004) Analysis of the transport properties of side chain modified dipeptides at the mammalian peptide transporter PEPT1. Eur. J. Pharm. Sci. 21, 61-67.
29. Thwaites, D.T., McEwan, G.T.A., Hirst, B.H. & Simmons, N.L. (1993) Transepithelial dipeptide (glycylsarcosine) transport across epithelial monolayers of human Caco-2 cells is rheogenic. Pflügers Arch. 425, 178-180.
30. Terada, T., Sawada, K., Ito, T., Saito, H., Hashimoto, Y. & Inui, K. (2000) Functional expression of novel peptide transporter in renal basolateral membranes. Am. J. Physiol. Renal Physiol. 279, F851-F857.
31. Terada, T., Sawada, K., Saito, H., Hashimoto, Y. & Inui, K. (1999) Functional characteristics of basolateral peptide transporter in the human intestinal cell line Caco-2. Am. J. Physiol. 276, G1435-G1441.